Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Association Between CD24-P226-C/T Polymorphism and Multiple Sclerosis: A Meta-Analysis.
The validity and reliability of the neurogenic bladder symptom score (NBSS).
Low dose naltrexone therapy in multiple sclerosis.
Human T cell expansion and experimental autoimmune encephalomyelitis inhibited by Lenaldekar, a small molecule discovered in a zebrafish screen.
Lipopolysaccharide Upregulates the Expression of CINC-3 and LIX in Primary NG2 Cells.
Treatment with natalizumab in relapsing-remitting multiple sclerosis patients induces changes in inflammatory mechanism.
Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis.
Lack of response to rituximab therapy in patients with neuromyelitis optica: Response to Kim and Kim.
First patient enrolled in third Phase III study of oral laquinimod for relapsing-remitting multiple sclerosis
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Role of adenosine in oligodendrocyte precursor maturation.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.
Epstein-Barr virus cause of multiple sclerosis.
Extracting quantitative measures from EAP: a small clinical study using BFOR.
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Pathology and disease mechanisms in different stages of multiple sclerosis.
Small Molecules in Stem Cell Research.
Comprehension and Data-Sharing Behavior of Direct-To-Consumer Genetic Test Customers.

Pages